Exercise and Nutrition on Obese Microbiome

January 3, 2020 updated by: Wesley Smith, University of Miami

The Effects of a Calorie-Restrictive Low-Carbohydrate Diet Versus an Unrestrictive Ancestral Diet on Microbiota and Cardiometabolic Disease Markers of Obese Individuals Performing an Intense Exercise Program

The purpose of this study is to examine the effects nine weeks of intense exercise training will have on weight, inflammation, and intestinal bacteria composition of overweight and obese adults.

Study Overview

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Miami, Florida, United States, 33146
        • University of Miami

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  1. Individuals who are overweight (BMI ≥ 25) and/or obese (BMI ≥ 30).
  2. Individuals who volunteer for the 54-day exercise program.
  3. Individuals with no history of diabetes mellitus (type I or II) or sickle cell disease.
  4. Individuals who are not taking antibiotics and have not taken antibiotics within 3 months.
  5. Individuals who are not taking probiotics.
  6. Individuals who are not taking Metformin.
  7. Individuals who are cleared by their physician to perform strenuous exercise.
  8. Individuals with no physically debilitating injuries that would keep them from being able to perform the exercises prescribed.
  9. Individuals who are between 18 and 60.

Exclusion criteria:

1. Any subjects who do not meet all of the inclusion criteria and/or are unable to consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise Only Group (EX)
Participants will only receive the exercise protocol without nutrition education or counseling and instructed to continue to consume their regular diet.
The exercise protocol consists of a nine-week progressive intense-conditioning program involving six consecutive days (Monday-Saturday) of one-hour exercises and one-day rest weekly for a total of 54 days of exercise. Exercises are performed in person as a group with other participating subjects and lead by certified instructors. Exercises will involve a variety of activities ranging from running, cycling, whole-body functional movements, power movements, and open-chain weight lifting with barbells and resistance bands.
Experimental: Exercise with CR-LC Group
Participants will receive the exercise protocol and CR-LC Diet regimen.
The exercise protocol consists of a nine-week progressive intense-conditioning program involving six consecutive days (Monday-Saturday) of one-hour exercises and one-day rest weekly for a total of 54 days of exercise. Exercises are performed in person as a group with other participating subjects and lead by certified instructors. Exercises will involve a variety of activities ranging from running, cycling, whole-body functional movements, power movements, and open-chain weight lifting with barbells and resistance bands.
Consists of weekly nutrition plans, counseling and monitoring by on-site registered dietitians and nutritionists for nine weeks. CR-LC consists of caloric and macronutrient restrictions. Caloric restrictions involves a 40% deficit from calculated total daily energy expenditure. Macronutrient restriction involves a high protein, low carbohydrate diet (35% protein, 25% carbohydrate and 40% fat).
Experimental: Exercise with Ancestral Diet (AD) Group
Participants will receive the exercise protocol and AD regimen.
The exercise protocol consists of a nine-week progressive intense-conditioning program involving six consecutive days (Monday-Saturday) of one-hour exercises and one-day rest weekly for a total of 54 days of exercise. Exercises are performed in person as a group with other participating subjects and lead by certified instructors. Exercises will involve a variety of activities ranging from running, cycling, whole-body functional movements, power movements, and open-chain weight lifting with barbells and resistance bands.
Consists of weekly nutrition plans, counseling and monitoring by on-site registered dietitians and nutritionists for nine weeks. AD consists of consuming only whole foods and avoiding processed foods. Emphasis will be on food quality with no caloric or macronutrient restrictions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in fecal microbiota diversity
Time Frame: Baseline, 9 weeks
Change in fecal microbiota alpha-diversity will be assessed via stool sample evaluation
Baseline, 9 weeks
Change in Bacteriodetes/Firmicutes ratio
Time Frame: Baseline, 9 weeks
Change in Bacteriodetes/Firmicutes ratio as assessed via stool sample evaluation
Baseline, 9 weeks
Percent change in fecal microbiota composition
Time Frame: Baseline, 9 weeks
Percent change in Bacteriodetes phyla and percent change of short-chain fatty acid-producing species as assessed via stool sample evaluation
Baseline, 9 weeks
Change in inflammatory markers
Time Frame: Baseline, 9 weeks
Change in serum inflammatory markers including Interleukin (IL)-1ß, IL-6, Tumor Necrosis Factor (TNF)-α and liposaccharide (LPS) evaluated in pg/ml.
Baseline, 9 weeks
Change in leptin/adiponectin ratio
Time Frame: Baseline, 9 weeks
Change in serum adipose markers assessed as change in leptin/adiponectin ratio.
Baseline, 9 weeks
Correlation of serum triglycerides with leptin levels
Time Frame: Baseline, 9 weeks
The correlation of the serum triglyceride levels will be evaluated against serum leptin levels.
Baseline, 9 weeks
Change in body weight
Time Frame: Baseline, 9 weeks
Change in body composition as evaluated as change in body weight measured in lbs.
Baseline, 9 weeks
Change in resting metabolic rate
Time Frame: Baseline, 9 weeks
Change in body composition as evaluated as change in resting metabolic rate measured in Calories per day.
Baseline, 9 weeks
Change in body composition
Time Frame: Baseline, 9 weeks
Change in body composition as evaluated as change in body fat and lean body mass percentage
Baseline, 9 weeks
Change in waist circumference
Time Frame: Baseline, 9 weeks
Change in waist circumference measured in inches.
Baseline, 9 weeks
Change in blood pressure
Time Frame: Baseline, 9 weeks
Change in blood pressure assessed as systolic and diastolic pressure in mmHg.
Baseline, 9 weeks
Change in visceral fat
Time Frame: Baseline, 9 weeks
Change in visceral fat levels will be measured using InBody570 with scores ranging from 1-20, with the higher score indicating increased visceral fat (worse outcome).
Baseline, 9 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wesley Smith, Ph.D., University of Miami

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2019

Primary Completion (Actual)

December 21, 2019

Study Completion (Actual)

December 21, 2019

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

October 22, 2019

First Posted (Actual)

October 24, 2019

Study Record Updates

Last Update Posted (Actual)

January 7, 2020

Last Update Submitted That Met QC Criteria

January 3, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20190936

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Exercise Protocol

3
Subscribe